Literature DB >> 8792769

Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

M P de Maat1, A C de Bart, B C Hennis, P Meijer, A C Havelaar, P G Mulder, C Kluft.   

Abstract

We compared intraindividual and interindividual variability in the plasma levels of fibrinogen, tissue-type plasminogen activator (TPA) antigen, plasminogen activator inhibitor (PAI) activity, and C-reactive protein (CRP) in 20 healthy, young individuals and 26 patients with stable angina pectoris (AP) who were at higher risk for cardiovascular disease. For each of the four parameters, the contribution of the intraindividual variation to the total variance (13% and 9% for fibrinogen, 3% and 5% for TPA antigen, 4% and 20% for In[PAI activity], and 14% and 9% for In[CRP] for the healthy volunteers and AP patients, respectively) was smaller than the contribution from the interindividual variation. These results indicate that single sampling is sufficient to assess an individual level for TPA antigen and PAI activity, whereas duplicate sampling for fibrinogen and triplicate sampling for CRP are recommended. In an epidemiological study the sample sizes, based on the variances found in the transverse part of the study, needed to detect a 15% difference between the two groups (with alpha = 0.01 and a statistical power = .90) are 31 and 40 for fibrinogen, 568 and 146 for TPA antigen, 603 and 119 for PAI activity, and 1490 and 2263 for CRP in healthy volunteers and patients with AP, respectively. Additionally, we studied the contribution of genetic polymorphisms of the B beta-fibrinogen (Bcl I and G-->A-455) and PAI activity (HindIII and CA-repeat) genes to intraindividual and interindividual variation. Fibrinogen genotypes were associated with plasma fibrinogen levels in the volunteers but not in the AP patients. No effects of fibrinogen or PAI polymorphisms on intraindividual variation were observed in either healthy individuals or AP patients. In this study intraindividual variation in plasma levels of the cardiovascular risk indicators fibrinogen, TPA antigen, PAI activity, and CRP was small when compared with the interindividual variation in healthy, young volunteers and patients with stable AP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792769     DOI: 10.1161/01.atv.16.9.1156

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  Precision of biomarkers to define chronic inflammation in CKD.

Authors:  Robert LaClair; Kalisha O'Neal; Susan Ofner; Marcelo J Sosa; Carlos A Labarrere; Sharon M Moe
Journal:  Am J Nephrol       Date:  2008-05-28       Impact factor: 3.754

Review 2.  Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.

Authors:  Allison E Aiello; George A Kaplan
Journal:  Biodemography Soc Biol       Date:  2009

3.  Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.

Authors:  Elizabeth A Platz; Siobhan Sutcliffe; Angelo M De Marzo; Charles G Drake; Nader Rifai; Ann W Hsing; Ashraful Hoque; Marian L Neuhouser; Phyllis J Goodman; Alan R Kristal
Journal:  Cancer Causes Control       Date:  2010-02-05       Impact factor: 2.506

4.  Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation.

Authors:  Wendy M R van Herpen-Broekmans; Ineke A A Klöpping-Ketelaars; Michiel L Bots; Cornelis Kluft; Hans Princen; Henk F J Hendriks; Lilian B M Tijburg; Geert van Poppel; Alwine F M Kardinaal
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 5.  Established and recently identified coronary heart disease risk factors in young people: the influence of physical activity and physical fitness.

Authors:  Non Eleri Thomas; Julien S Baker; Bruce Davies
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

6.  Discordances among different tools used to estimate cardiovascular risk in postmenopausal women.

Authors:  Pascal Pelletier; Annie Lapointe; Nathalie Laflamme; Marie-Eve Piché; Stanley John Weisnagel; André Nadeau; Simone Lemieux; Jean Bergeron
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

7.  C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells.

Authors:  Changyi Chen; Bicheng Nan; Peter Lin; Qizhi Yao
Journal:  Thromb Res       Date:  2007-10-22       Impact factor: 3.944

8.  Long-term C-reactive protein variability and prediction of metabolic risk.

Authors:  Ting-hsu Chen; Philimon Gona; Patrice A Sutherland; Emelia J Benjamin; Peter W F Wilson; Martin G Larson; Ramachandran S Vasan; Sander J Robins
Journal:  Am J Med       Date:  2009-01       Impact factor: 4.965

9.  Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals.

Authors:  Sandi L Navarro; Theodore M Brasky; Yvonne Schwarz; Xiaoling Song; C Y Wang; Alan R Kristal; Mario Kratz; Emily White; Johanna W Lampe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

10.  Within-person variability in high-sensitivity C-reactive protein.

Authors:  Julie K Bower; Mariana Lazo; Stephen P Juraschek; Elizabeth Selvin
Journal:  Arch Intern Med       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.